Elective Cardiac Surgery

2

Review clinical trials related to Elective Cardiac Surgery. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Intravenous Fish Oil Based Lipid Emulsion to Enhance Recovery in High-Risk Cardiac Surgery Patients

The MODIFY CSX study is a prospective, randomized, placebo-controlled trial conducted in heart centers in Germany and Italy. A total of 550 high-risk cardiac surgery patients will receive either 0.20 g fish oil/kg body weight (BW) + standard of care versus same volume of placebo (NaCl) + standard of care.

Participants needed: 550
Trial details
Phase: Phase 2Age: 18+Biological sex: AllType: InterventionalSponsor: GCP-Service International West GmbHUpdated: Feb 23, 2026Locations: 10
Eligibility criteria

Written informed consent prior to study participation [+2]

Known hypersensitivity to fish oil/fish products or egg protein [+13]

Status: Recruiting

Parasternal Blockade and Serum Lactate in Cardiac Surgery

Serum lactate level is a key indicator of tissue perfusion. Parasternal blockade is associated with reduced postoperative inflammatory response by inhibiting stress response, leading to better outcomes. Elevated lactate levels help identify patients at risk of postoperative morbidity and mortality. This analytical cross-sectional study evaluated the association between parasternal blockade and serum lactate levels in patients undergoing elective cardiac surgery in 2022 at Specialty Hospital CMNO. Patients with and without parasternal block were compared for changes in serum lactate levels during and after anesthesia within the first 24 hours.

Participants needed: 86
Trial details
Age: 18+Biological sex: AllType: InterventionalSponsor: Instituto Mexicano del Seguro SocialUpdated: Jul 24, 2024Locations: 1
Eligibility criteria

Adult patients older than 18 years [+3]

Patients with pre-existing conditions that could independently affect serum lact...